Testimony of Jack E. Henningfield, Ph.D.

November 29, 2004 1:24 am by Gene Borio

Testimony of Jack E. Henningfield, Ph.D.

From the DOJ Witness List:

Henningfield, Jack

US Expert Witness

Dr. Henningfield received his B.A. in Psychology from the University of Minnesota in 1974 and his PhD. in Experimental Psychology in Psychopharmacology from the same school in 1977. He currently works as an Associate Professor of Behavioral Biology, Department of Psychiatry and Behavioral Sciences at the Johns Hopkins University School of Medicine in Baltimore, Maryland, a position he has held since 1989. He also works as a Vice President for Research and Health Policy at Pinney Associates, a consulting firm devoted to health and medical issues related to the development of treatment for medical disorders, including tobacco dependence. Dr. Henningfield is active in a number of scientific professional organizations that address drug addiction, medication development and public health, including the American College of Neuropsychopharmacology, the American Psychological Association, the College on Problems of Drug Dependence, the International Study Group Investigating Drugs as Reinforcers, and the Society for Research on Nicotine and Tobacco.

Dr. Henningfield received his training as a specialist in drugs of abuse at the University of Minnesota during the 1970’s. In 1978, Dr. Henningfield began working at the Johns Hopkins Medical School, where he helped to develop a human tobacco research program. In 1980, Dr. Henningfield was recruited by the Addiction Research Center of the National Institute on Drug Abuse (”NIDA”) (part of the National Institutes of Health) to help develop a program of human research on tobacco and nicotine and conduct research involving other addictive and behaviorally active drugs, including cocaine, heroin, alcohol and amphetamines. Dr. Henningfield went on to serve as one of NIDA’s lead scientists and advisors on issues pertaining to tobacco and nicotine and nicotine dependence medications development. In these roles, Dr. Henningfield assisted several NIDA directors in developing their testimony to Congress on tobacco-related topics, represented NIDA before Congress and several government agencies and helped to develop the Agency for Healthcare Research and Policy’s Clinical Practice Guidelines on Smoking Cessation. Finally, from 1994 until 1996, Dr. Henningfield served as NIDA’s chief scientific advisor to the Federal Drug Administration during the development and consideration of its Tobacco Rule. In this role, Dr. Henningfield reviewed and assisted in the development of responses to the tobacco industry’s comments on the Rule. On August 31, 1996, Dr. Henningfield, then Chief of the Biology of Dependence and Abuse Potential Assessment, and Clinical Pharmacology Research branches at NIDA, retired and then joined Pinney Associates.

In his career, Dr. Henningfield has published approximately 300 scientific papers and review articles on the various aspects of drug abuse and addiction. More than half of these papers and articles address tobacco and nicotine-related topics. Dr. Henningfield has also contributed to several Surgeon General Reports, including serving as a Scientific Editor for the 1988 Report entitled The Health Consequences of Smoking-Nicotine Addiction. Dr. Henningfield has testified in numerous smoking and health cases, involving both individual smoker and class action cases.

Leave a Reply

The primary purpose of this site is to provide information in a timely manner. Postings should be informative. The usual rules apply: No libel, no profanity, no personal abuse, keep it on topic, and short.

If you are scheduled as a court witness, CHECK with your lawyer before posting anything here!